0001214659-19-007463.txt : 20191129 0001214659-19-007463.hdr.sgml : 20191129 20191129134115 ACCESSION NUMBER: 0001214659-19-007463 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191126 FILED AS OF DATE: 20191129 DATE AS OF CHANGE: 20191129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Finn Patrick John CENTRAL INDEX KEY: 0001755970 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38720 FILM NUMBER: 191260800 MAIL ADDRESS: STREET 1: C/O TWIST BIOSCIENCE CORPORATION STREET 2: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Twist Bioscience Corp CENTRAL INDEX KEY: 0001581280 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 462058888 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 681 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 800-719-0671 MAIL ADDRESS: STREET 1: 681 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 marketforms-46429.xml PRIMARY DOCUMENT X0306 4 2019-11-26 0001581280 Twist Bioscience Corp TWST 0001755970 Finn Patrick John C/O TWIST BIOSCIENCE CORPORATION 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 false true false false Chief Commercial Officer Common Stock 2019-11-26 4 M false 33000 5.95 A 75596 D Common Stock 2019-11-27 4 S false 36932 23.3199 D 38664 D Employee Stock Option (right to buy) 5.95 2019-11-26 4 M false 33000 0 D 2025-09-29 Common Stock 33000 6875 D The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Represents the aggregate of sales effected on the same day at different prices. Represents the weighted average sales price per share. The shares sold at prices ranging from $23.00 to $23.75 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. The option is immediately exercisable. 25% of the shares subject to the option vested on September 01, 2016, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. /s/ William Solis, as Attorney-in-Fact for Patrick John Finn 2019-11-29